Abstract -The alkaloid (+)-sesbanimide A , first isolated from the seeds of Sesbania drummondii, possesses potent antileukemic properties. A strategy for the total synthesis of the alkaloid has been developed which has led to both, the naturally occurring product, and its antipode, namely, (-)-7R,8S,9R, lOS, 11.3-sesbanimide A. The first synthesis of this compound established the absolute stereochemistry of the natural alkaloid. The synthetic strategy is being further developed for the synthesis of new "sesbanimides" for structure-activity relationship studies. A programme directed at the synthesis of sesbanimides was initiated in our laboratory, with the aim of developing structure-activity relationship within this class of alkaloids and ultimately designing a clinically useful anti-cancer drug.
In an initial approach to 1, but Although the regiospecific opening of one of the two methylene acetal groups in 2, namely 3 -4 , was easily achieved, suitable protection of the secondary hydroxyl group in diol f! did not prove to be straightforward. Reacetalization of the diol function in 4 with 3,4-dimethoxybenzaldehyde and subsequent diethylaluminium chloride mediated reductive ring-opening yielded the desired primary alcohol, which was oxidized to the crucial intermediate 2.
ring C precursor was attached to the aldehydic carbon of intermediate r in the form of allylsilane derivative 5 (BF3.Et20, -9OOC).
stereochemical control, and a mixture of diastereomeric alcohols '&,b was produced.
quently, the mixture (s,a) was separated, the correct diastereomer oxidized and the protecting groups removed, whereupon, hemiacetal 8 was obtained as a crystalline product.
latter compound was identical to the natural alkaloid in all respects, except its optical rotation. Consequently, this sequence of reactions (Scheme I), which lead to In view of the aforementioned results, we undertook the application of the strategy developed in our laboratory to the synthesis of (+)-sesbanimide A (SchemeII). Construction of the glutarimide ring on 9 followed the steps ( 2 , 3) shown in Scheme I.
resulting product lo was debenzylated to diol 11, which is chemically identical to diol 4.
The diol 11 was then subjected to the sequence of transformations described in Scheme I. steps proceeded in the expected manner, to yield crystalline (+)-sesbanimide A (1) The mode of action of sesbanimide is not known at present. the various congeners of sesbanimides and their transformation products (ref. 21, no information is available on structure-activity relationship. With the availability of ( + ) -and (-1-sesbanimides A and several partial structures involving AB and BC ring systems, a structure-activity study has been initiated. The results of the in vivo tests using P-388 murine leukemia are presented in Table I . The difference in the behaviour of ( + ) -and (-)-sesbanimides in this test, points to the striking role of stereochemistry of the molecule in the expression of its biological activity. The total lack of activity of compounds 12-16, suggests that all three rings are a necessary minimum structural requirement for activity; although in case of 15 and 16 this conclusion should be tempered, since the stereochemistry of the sugar moiety corresponds to (-)-sesbanimide, which is itself inactive. It is noteworthy that the a-methylene lactone derivative fi is inactive, even at a high dose level. However, this result need not have implications for the suggestion (ref. 9) that sesbanimides might function via a C (~~) -O X O metabolite. It is apparent that ideas on the mechanism of action and structure activity relationship shall have to await further work.
From the data in Table I it follows that modifications of sesbanimide A for development as a potential drug, shall have to be based upon a 7S,8R,9S-configuration of the chiral centres in ring B. With this in mind, we have currently directed our attention to the modification of ring C, which, it is intuitively felt, may somehow be chemically involved in the bio-activity of the alkaloid. In order to synthesize ring C modified analogs of (+I-sesbanimide A, access to adequate quantities of the AB-aldehyde intermediate fi is required.
for the synthesis of 5 and its antipode molecule (utilized in Scheme II), is quite effective especially when working with modest amounts of materials. In view of this, we have examined other potential approaches for the synthesis of aldehyde (fi), o r its immediate precursor g.
Consideration of procedures for the differential protection of the hydroxyl functions in diol -1 1 , led us to examine sequential acylation and silylation of the primary and secondary hydroxyl groups, respectively. Such an approach has been employed by Schlessinger (ref. 10) and Terashima (ref. 11) in connection with the synthesis of sesbanimides. In our hands the best results were obtained when the primary hydroxyl group of 11 was benzoylated to ester B, the latter silylated with tertiary butyldiphenylsilyltrifluoromethanesulfonate and the resulting product subsequently treated with diisobutylaluminiumhydride (DIBAH). In accordance with the Also, except for limited data on
The approach described in Scheme I Synthetic studies on sesbanimides T& i Activity against P388 murine leukemia in vivo 100 mg I kg inactiveb anticipated and assumed (refs 10, 11) course of the reactions, the aforementioned two products should possess structures * and -.
tives are not in agreement with the structures previously assigned to them (refs 10, 11) . On the basis of COSY, C-H correlation, l3C NMR (APT, DEPT) and Nuclear Overhauser difference experiments, structure + is assigned to the silylated benzoate ester.
vance to this conclusion are the following data. carbons (6 165 and 170 ppm) are visible and a tertiary carbon is identified at 6 101 ppm. The latter can be assigned to a carbon bonded to two oxygens and a nitrogen atom [C(2) in -2Oal. 
